Armistice Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.6M | Buy |
16,150,000
+2,450,000
| +18% | +$1.76M | 0.2% | 59 |
|
|
2025
Q1 | $20.1M | Buy |
13,700,000
+4,232,000
| +45% | +$6.22M | 0.3% | 58 |
|
|
2024
Q4 | $41.9M | Buy |
9,468,000
+1,268,000
| +15% | +$5.62M | 0.57% | 31 |
|
|
2024
Q3 | $33.8M | Buy |
8,200,000
+400,000
| +5% | +$1.65M | 0.54% | 31 |
|
|
2024
Q2 | $50.9M | Buy |
7,800,000
+2,400,000
| +44% | +$15.6M | 0.64% | 20 |
|
|
2024
Q1 | $47M | Sell |
5,400,000
-300,000
| -5% | -$2.61M | 0.62% | 20 |
|
|
2023
Q4 | $65.2M | Buy |
5,700,000
+2,244,000
| +65% | +$25.7M | 0.89% | 17 |
|
|
2023
Q3 | $33.3M | Buy |
+3,456,000
| New | +$33.3M | 0.51% | 35 |
|